Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Prediction and assessment of splicing alterations: implications for clinical testing

Identifieur interne : 008757 ( Main/Exploration ); précédent : 008756; suivant : 008758

Prediction and assessment of splicing alterations: implications for clinical testing

Auteurs : Amanda B. Spurdle [Australie] ; Fergus J. Couch [États-Unis] ; Frans B. L. Hogervorst [Pays-Bas] ; Paolo Radice [Italie] ; Olga M. Sinilnikova [France]

Source :

RBID : ISTEX:AE892D8CFB864DD2D195E44DF4E267CD5ADABFC5

Descripteurs français

English descriptors

Abstract

Sequence variants that may result in splicing alterations are a particular class of inherited variants for which consequences can be more readily assessed, using a combination of bioinformatic prediction methods and in vitro assays. There is also a general agreement that a variant would invariably be considered pathogenic on the basis of convincing evidence that it results in transcript(s) carrying a premature stop codon or an in‐frame deletion disrupting known functional domain(s). This commentary discusses current practices used to assess the clinical significance of this class of variants, provides suggestions to improve assessment, and highlights the issues involved in routine assessment of potential splicing aberrations. We conclude that classification of sequence variants that may alter splicing is greatly enhanced by supporting in vitro analysis. Additional studies that assess large numbers of variants for induction of splicing aberrations and exon skipping are needed to define the contribution of splicing/exon skipping to cancer and disease. These studies will also provide the impetus for development of algorithms that better predict splicing patterns. To facilitate variant classification and development of more specific bioinformatic tools, we call for the deposition of all laboratory data from splicing analyses into national and international databases. Hum Mutat 29(11), 1304–1313, 2008. © 2008 Wiley‐Liss, Inc.

Url:
DOI: 10.1002/humu.20901


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Prediction and assessment of splicing alterations: implications for clinical testing</title>
<author>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
</author>
<author>
<name sortKey="Couch, Fergus J" sort="Couch, Fergus J" uniqKey="Couch F" first="Fergus J." last="Couch">Fergus J. Couch</name>
</author>
<author>
<name sortKey="Hogervorst, Frans B L" sort="Hogervorst, Frans B L" uniqKey="Hogervorst F" first="Frans B. L." last="Hogervorst">Frans B. L. Hogervorst</name>
</author>
<author>
<name sortKey="Radice, Paolo" sort="Radice, Paolo" uniqKey="Radice P" first="Paolo" last="Radice">Paolo Radice</name>
</author>
<author>
<name sortKey="Sinilnikova, Olga M" sort="Sinilnikova, Olga M" uniqKey="Sinilnikova O" first="Olga M." last="Sinilnikova">Olga M. Sinilnikova</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AE892D8CFB864DD2D195E44DF4E267CD5ADABFC5</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/humu.20901</idno>
<idno type="url">https://api.istex.fr/document/AE892D8CFB864DD2D195E44DF4E267CD5ADABFC5/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002119</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002119</idno>
<idno type="wicri:Area/Istex/Curation">002119</idno>
<idno type="wicri:Area/Istex/Checkpoint">001124</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001124</idno>
<idno type="wicri:doubleKey">1059-7794:2008:Spurdle A:prediction:and:assessment</idno>
<idno type="wicri:source">PMC</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832470</idno>
<idno type="RBID">PMC:2832470</idno>
<idno type="wicri:Area/Pmc/Corpus">001479</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">001479</idno>
<idno type="wicri:Area/Pmc/Curation">001339</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">001339</idno>
<idno type="wicri:Area/Pmc/Checkpoint">002938</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002938</idno>
<idno type="wicri:Area/Ncbi/Merge">000470</idno>
<idno type="wicri:Area/Ncbi/Curation">000470</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000470</idno>
<idno type="wicri:doubleKey">1059-7794:2008:Spurdle A:prediction:and:assessment</idno>
<idno type="wicri:Area/Main/Merge">009018</idno>
<idno type="wicri:Area/Main/Curation">008757</idno>
<idno type="wicri:Area/Main/Exploration">008757</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Prediction and assessment of splicing alterations: implications for clinical testing
<ref type="note" target="#fn1"></ref>
</title>
<author>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Genetics and Population Health Division, Queensland Institute of Medical Research, Brisbane</wicri:regionArea>
<wicri:noRegion>Brisbane</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1">
<country wicri:rule="url">Australie</country>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Correspondence address: Genetics and Population Health Division, Queensland Institute of Medical Research, PO Royal Brisbane Hospital, Herston, Brisbane, 4029</wicri:regionArea>
<wicri:noRegion>4029</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Couch, Fergus J" sort="Couch, Fergus J" uniqKey="Couch F" first="Fergus J." last="Couch">Fergus J. Couch</name>
<affiliation wicri:level="2">
<country xml:lang="fr">États-Unis</country>
<placeName>
<region type="state">Minnesota</region>
</placeName>
<wicri:cityArea>Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Hogervorst, Frans B L" sort="Hogervorst, Frans B L" uniqKey="Hogervorst F" first="Frans B. L." last="Hogervorst">Frans B. L. Hogervorst</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Pays-Bas</country>
<wicri:regionArea>DNA‐Diagnostic Laboratory of the Family Cancer Clinic, Department of Pathology, The Netherlands Cancer Institute, Amsterdam</wicri:regionArea>
<placeName>
<settlement type="city">Amsterdam</settlement>
<region nuts="2" type="province">Hollande-Septentrionale</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Radice, Paolo" sort="Radice, Paolo" uniqKey="Radice P" first="Paolo" last="Radice">Paolo Radice</name>
<affiliation wicri:level="3">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Fondazione Istituto FIRC di Oncologia Molecolare (IFOM), Milan</wicri:regionArea>
<placeName>
<settlement type="city">Milan</settlement>
<region nuts="2">Lombardie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Sinilnikova, Olga M" sort="Sinilnikova, Olga M" uniqKey="Sinilnikova O" first="Olga M." last="Sinilnikova">Olga M. Sinilnikova</name>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon/Centre Léon Bérard, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
<affiliation wicri:level="3">
<country xml:lang="fr">France</country>
<wicri:regionArea>Laboratoire de Génétique Moléculaire, Signalisation et Cancer, UMR5201 CNRS, Université Lyon 1, Lyon</wicri:regionArea>
<placeName>
<region type="region">Auvergne-Rhône-Alpes</region>
<region type="old region">Rhône-Alpes</region>
<settlement type="city">Lyon</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Human Mutation</title>
<title level="j" type="sub">Special Issue: Assessing Mutation Pathogenicity in Cancer Susceptibility Genes</title>
<title level="j" type="alt">HUMAN MUTATION</title>
<idno type="ISSN">1059-7794</idno>
<idno type="eISSN">1098-1004</idno>
<imprint>
<biblScope unit="vol">29</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1304">1304</biblScope>
<biblScope unit="page" to="1313">1313</biblScope>
<biblScope unit="page-count">10</biblScope>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-11">2008-11</date>
</imprint>
<idno type="ISSN">1059-7794</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1059-7794</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Aberrant</term>
<term>Aberration</term>
<term>Acceptor</term>
<term>Acceptor sites</term>
<term>Acceptor splice sites</term>
<term>Additional funding</term>
<term>Additional studies</term>
<term>Algorithm</term>
<term>Allele</term>
<term>Alteration</term>
<term>Assay</term>
<term>Bioinformatic</term>
<term>Bioinformatic analyses</term>
<term>Bioinformatic analysis</term>
<term>Bioinformatic prediction</term>
<term>Bioinformatic predictions</term>
<term>Bioinformatic programs</term>
<term>Bioinformatic tools</term>
<term>Blood samples</term>
<term>Boundarye exonic variants</term>
<term>Branch point sites</term>
<term>Brca1</term>
<term>Brca1 brct</term>
<term>Brca1 exon</term>
<term>Brca1 ring</term>
<term>Brca2</term>
<term>Brca2 variants</term>
<term>Breast cancer</term>
<term>Burge</term>
<term>Cancer research</term>
<term>Cancer risk</term>
<term>Cell type</term>
<term>Clinical laboratories</term>
<term>Clinical management</term>
<term>Clinical relevance</term>
<term>Clinical significance</term>
<term>Clinical testing</term>
<term>Codon</term>
<term>Computational</term>
<term>Computational tools</term>
<term>Consensus splice regions</term>
<term>Consensus splice sites</term>
<term>Considerable evidence</term>
<term>Convincing evidence</term>
<term>Cryptic site</term>
<term>Cryptic splice site</term>
<term>Cryptic splice sites</term>
<term>Current data</term>
<term>Current practices</term>
<term>Default settings</term>
<term>Deletion</term>
<term>Donor sites</term>
<term>Easton</term>
<term>Easy retrieval</term>
<term>Ectopic splice sites</term>
<term>Enhancer</term>
<term>Es</term>
<term>Exon</term>
<term>Exonic</term>
<term>Exonic missense</term>
<term>Exonic regions</term>
<term>Exonic variants</term>
<term>Experimental evidence</term>
<term>Fasta</term>
<term>Fasta format</term>
<term>Fresh blood</term>
<term>Further data</term>
<term>Further development</term>
<term>Further information</term>
<term>Further study</term>
<term>Genet</term>
<term>Genetic variants</term>
<term>Goldgar</term>
<term>Grant number</term>
<term>Grant sponsor</term>
<term>Graphical output</term>
<term>Higher level</term>
<term>Hospices civils</term>
<term>Human disease genes</term>
<term>Human mutation</term>
<term>Iarc</term>
<term>Information theory</term>
<term>Inframe deletions</term>
<term>International databases</term>
<term>Intronic</term>
<term>Intronic variants</term>
<term>Italian association</term>
<term>Laboratory data</term>
<term>Large numbers</term>
<term>Mayo clinic</term>
<term>Medical research</term>
<term>Medical research council</term>
<term>Missense</term>
<term>Missense substitution</term>
<term>Missense substitutions</term>
<term>Missense variants</term>
<term>Mrna</term>
<term>Multifactorial</term>
<term>Multifactorial likelihood analysis</term>
<term>Multifactorial likelihood approaches</term>
<term>Mutat</term>
<term>Mutation</term>
<term>Mutation pattern</term>
<term>Netherlands cancer institute</term>
<term>Nucleic</term>
<term>Nucleic acids</term>
<term>Nucleotide</term>
<term>Nucleotide structure</term>
<term>Other alterations</term>
<term>Other exonic</term>
<term>Particular class</term>
<term>Pathogenic</term>
<term>Physiological alternative</term>
<term>Population health division</term>
<term>Posterior probability</term>
<term>Prediction</term>
<term>Prediction programs</term>
<term>Queensland institute</term>
<term>Rare sequence variants</term>
<term>Routine assessment</term>
<term>Sequence alterations</term>
<term>Sequence change</term>
<term>Sequence changes</term>
<term>Sequence information</term>
<term>Sequence motifs</term>
<term>Sequence statistics</term>
<term>Sequence variants</term>
<term>Silent mutations</term>
<term>Similar transcripts</term>
<term>Single sequences</term>
<term>Splice</term>
<term>Splice acceptor sites</term>
<term>Splice donor</term>
<term>Splice junctions</term>
<term>Splice products</term>
<term>Splice site</term>
<term>Splice site prediction</term>
<term>Splice sites</term>
<term>Substitution</term>
<term>Such assays</term>
<term>Such variants</term>
<term>Target tissue</term>
<term>Tavtigian</term>
<term>Threshold alteration</term>
<term>Transcript</term>
<term>Uncertain significance</term>
<term>Unclassified variants</term>
<term>Unpublished data</term>
<term>Variant</term>
<term>Variant allele</term>
<term>Variant carrier</term>
<term>Variant classification</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en">
<term>Aberrant</term>
<term>Aberration</term>
<term>Acceptor</term>
<term>Acceptor sites</term>
<term>Acceptor splice sites</term>
<term>Additional funding</term>
<term>Additional studies</term>
<term>Algorithm</term>
<term>Allele</term>
<term>Alteration</term>
<term>Assay</term>
<term>Bioinformatic</term>
<term>Bioinformatic analyses</term>
<term>Bioinformatic analysis</term>
<term>Bioinformatic prediction</term>
<term>Bioinformatic predictions</term>
<term>Bioinformatic programs</term>
<term>Bioinformatic tools</term>
<term>Blood samples</term>
<term>Boundarye exonic variants</term>
<term>Branch point sites</term>
<term>Brca1</term>
<term>Brca1 brct</term>
<term>Brca1 exon</term>
<term>Brca1 ring</term>
<term>Brca2</term>
<term>Brca2 variants</term>
<term>Breast cancer</term>
<term>Burge</term>
<term>Cancer research</term>
<term>Cancer risk</term>
<term>Cell type</term>
<term>Clinical laboratories</term>
<term>Clinical management</term>
<term>Clinical relevance</term>
<term>Clinical significance</term>
<term>Clinical testing</term>
<term>Codon</term>
<term>Computational</term>
<term>Computational tools</term>
<term>Consensus splice regions</term>
<term>Consensus splice sites</term>
<term>Considerable evidence</term>
<term>Convincing evidence</term>
<term>Cryptic site</term>
<term>Cryptic splice site</term>
<term>Cryptic splice sites</term>
<term>Current data</term>
<term>Current practices</term>
<term>Default settings</term>
<term>Deletion</term>
<term>Donor sites</term>
<term>Easton</term>
<term>Easy retrieval</term>
<term>Ectopic splice sites</term>
<term>Enhancer</term>
<term>Es</term>
<term>Exon</term>
<term>Exonic</term>
<term>Exonic missense</term>
<term>Exonic regions</term>
<term>Exonic variants</term>
<term>Experimental evidence</term>
<term>Fasta</term>
<term>Fasta format</term>
<term>Fresh blood</term>
<term>Further data</term>
<term>Further development</term>
<term>Further information</term>
<term>Further study</term>
<term>Genet</term>
<term>Genetic variants</term>
<term>Goldgar</term>
<term>Grant number</term>
<term>Grant sponsor</term>
<term>Graphical output</term>
<term>Higher level</term>
<term>Hospices civils</term>
<term>Human disease genes</term>
<term>Human mutation</term>
<term>Iarc</term>
<term>Information theory</term>
<term>Inframe deletions</term>
<term>International databases</term>
<term>Intronic</term>
<term>Intronic variants</term>
<term>Italian association</term>
<term>Laboratory data</term>
<term>Large numbers</term>
<term>Mayo clinic</term>
<term>Medical research</term>
<term>Medical research council</term>
<term>Missense</term>
<term>Missense substitution</term>
<term>Missense substitutions</term>
<term>Missense variants</term>
<term>Mrna</term>
<term>Multifactorial</term>
<term>Multifactorial likelihood analysis</term>
<term>Multifactorial likelihood approaches</term>
<term>Mutat</term>
<term>Mutation</term>
<term>Mutation pattern</term>
<term>Netherlands cancer institute</term>
<term>Nucleic</term>
<term>Nucleic acids</term>
<term>Nucleotide</term>
<term>Nucleotide structure</term>
<term>Other alterations</term>
<term>Other exonic</term>
<term>Particular class</term>
<term>Pathogenic</term>
<term>Physiological alternative</term>
<term>Population health division</term>
<term>Posterior probability</term>
<term>Prediction</term>
<term>Prediction programs</term>
<term>Queensland institute</term>
<term>Rare sequence variants</term>
<term>Routine assessment</term>
<term>Sequence alterations</term>
<term>Sequence change</term>
<term>Sequence changes</term>
<term>Sequence information</term>
<term>Sequence motifs</term>
<term>Sequence statistics</term>
<term>Sequence variants</term>
<term>Silent mutations</term>
<term>Similar transcripts</term>
<term>Single sequences</term>
<term>Splice</term>
<term>Splice acceptor sites</term>
<term>Splice donor</term>
<term>Splice junctions</term>
<term>Splice products</term>
<term>Splice site</term>
<term>Splice site prediction</term>
<term>Splice sites</term>
<term>Substitution</term>
<term>Such assays</term>
<term>Such variants</term>
<term>Target tissue</term>
<term>Tavtigian</term>
<term>Threshold alteration</term>
<term>Transcript</term>
<term>Uncertain significance</term>
<term>Unclassified variants</term>
<term>Unpublished data</term>
<term>Variant</term>
<term>Variant allele</term>
<term>Variant carrier</term>
<term>Variant classification</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Recherche médicale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Sequence variants that may result in splicing alterations are a particular class of inherited variants for which consequences can be more readily assessed, using a combination of bioinformatic prediction methods and in vitro assays. There is also a general agreement that a variant would invariably be considered pathogenic on the basis of convincing evidence that it results in transcript(s) carrying a premature stop codon or an in‐frame deletion disrupting known functional domain(s). This commentary discusses current practices used to assess the clinical significance of this class of variants, provides suggestions to improve assessment, and highlights the issues involved in routine assessment of potential splicing aberrations. We conclude that classification of sequence variants that may alter splicing is greatly enhanced by supporting in vitro analysis. Additional studies that assess large numbers of variants for induction of splicing aberrations and exon skipping are needed to define the contribution of splicing/exon skipping to cancer and disease. These studies will also provide the impetus for development of algorithms that better predict splicing patterns. To facilitate variant classification and development of more specific bioinformatic tools, we call for the deposition of all laboratory data from splicing analyses into national and international databases. Hum Mutat 29(11), 1304–1313, 2008. © 2008 Wiley‐Liss, Inc.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Australie</li>
<li>France</li>
<li>Italie</li>
<li>Pays-Bas</li>
<li>États-Unis</li>
</country>
<region>
<li>Auvergne-Rhône-Alpes</li>
<li>Hollande-Septentrionale</li>
<li>Lombardie</li>
<li>Minnesota</li>
<li>Rhône-Alpes</li>
</region>
<settlement>
<li>Amsterdam</li>
<li>Lyon</li>
<li>Milan</li>
</settlement>
</list>
<tree>
<country name="Australie">
<noRegion>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
</noRegion>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
<name sortKey="Spurdle, Amanda B" sort="Spurdle, Amanda B" uniqKey="Spurdle A" first="Amanda B." last="Spurdle">Amanda B. Spurdle</name>
</country>
<country name="États-Unis">
<region name="Minnesota">
<name sortKey="Couch, Fergus J" sort="Couch, Fergus J" uniqKey="Couch F" first="Fergus J." last="Couch">Fergus J. Couch</name>
</region>
</country>
<country name="Pays-Bas">
<region name="Hollande-Septentrionale">
<name sortKey="Hogervorst, Frans B L" sort="Hogervorst, Frans B L" uniqKey="Hogervorst F" first="Frans B. L." last="Hogervorst">Frans B. L. Hogervorst</name>
</region>
</country>
<country name="Italie">
<region name="Lombardie">
<name sortKey="Radice, Paolo" sort="Radice, Paolo" uniqKey="Radice P" first="Paolo" last="Radice">Paolo Radice</name>
</region>
<name sortKey="Radice, Paolo" sort="Radice, Paolo" uniqKey="Radice P" first="Paolo" last="Radice">Paolo Radice</name>
</country>
<country name="France">
<region name="Auvergne-Rhône-Alpes">
<name sortKey="Sinilnikova, Olga M" sort="Sinilnikova, Olga M" uniqKey="Sinilnikova O" first="Olga M." last="Sinilnikova">Olga M. Sinilnikova</name>
</region>
<name sortKey="Sinilnikova, Olga M" sort="Sinilnikova, Olga M" uniqKey="Sinilnikova O" first="Olga M." last="Sinilnikova">Olga M. Sinilnikova</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 008757 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 008757 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:AE892D8CFB864DD2D195E44DF4E267CD5ADABFC5
   |texte=   Prediction and assessment of splicing alterations: implications for clinical testing
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024